BLOOMIN' BRANDS INC (BLMN)

US0942351083 - Common Stock

27.04  +0.01 (+0.04%)

After market: 27.04 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to BLMN. BLMN was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. BLMN has an excellent profitability rating, but there are concerns on its financial health. BLMN is valued quite cheap, while showing a decent growth score. This is a good combination!



7

1. Profitability

1.1 Basic Checks

In the past year BLMN was profitable.
In the past year BLMN had a positive cash flow from operations.
BLMN had positive earnings in 4 of the past 5 years.
BLMN had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 7.22%, BLMN belongs to the top of the industry, outperforming 80.60% of the companies in the same industry.
Looking at the Return On Equity, with a value of 60.46%, BLMN belongs to the top of the industry, outperforming 96.27% of the companies in the same industry.
BLMN has a better Return On Invested Capital (12.43%) than 79.10% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for BLMN is above the industry average of 10.32%.
Industry RankSector Rank
ROA 7.22%
ROE 60.46%
ROIC 12.43%
ROA(3y)5.61%
ROA(5y)3.13%
ROE(3y)65.87%
ROE(5y)-736.36%
ROIC(3y)12.79%
ROIC(5y)N/A

1.3 Margins

Looking at the Profit Margin, with a value of 5.30%, BLMN is in line with its industry, outperforming 55.97% of the companies in the same industry.
BLMN's Profit Margin has improved in the last couple of years.
BLMN has a Operating Margin (7.80%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BLMN has grown nicely.
Looking at the Gross Margin, with a value of 69.83%, BLMN belongs to the top of the industry, outperforming 82.09% of the companies in the same industry.
In the last couple of years the Gross Margin of BLMN has remained more or less at the same level.
Industry RankSector Rank
OM 7.8%
PM (TTM) 5.3%
GM 69.83%
OM growth 3YN/A
OM growth 5Y11.7%
PM growth 3YN/A
PM growth 5Y15.33%
GM growth 3Y0.22%
GM growth 5Y0.35%

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), BLMN is creating some value.
BLMN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for BLMN has been reduced compared to 5 years ago.
BLMN has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that BLMN is in the distress zone and has some risk of bankruptcy.
BLMN has a Altman-Z score of 1.74. This is comparable to the rest of the industry: BLMN outperforms 51.49% of its industry peers.
The Debt to FCF ratio of BLMN is 3.80, which is a good value as it means it would take BLMN, 3.80 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of BLMN (3.80) is better than 79.10% of its industry peers.
A Debt/Equity ratio of 1.93 is on the high side and indicates that BLMN has dependencies on debt financing.
With a Debt to Equity ratio value of 1.93, BLMN perfoms like the industry average, outperforming 52.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF 3.8
Altman-Z 1.74
ROIC/WACC1.42
WACC8.74%

2.3 Liquidity

A Current Ratio of 0.34 indicates that BLMN may have some problems paying its short term obligations.
BLMN has a Current ratio of 0.34. This is amonst the worse of the industry: BLMN underperforms 91.79% of its industry peers.
A Quick Ratio of 0.27 indicates that BLMN may have some problems paying its short term obligations.
The Quick ratio of BLMN (0.27) is worse than 92.54% of its industry peers.
Industry RankSector Rank
Current Ratio 0.34
Quick Ratio 0.27

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.94% over the past year.
The Earnings Per Share has been growing by 14.33% on average over the past years. This is quite good.
BLMN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.77%.
Measured over the past years, BLMN shows a small growth in Revenue. The Revenue has been growing by 2.51% on average per year.
EPS 1Y (TTM)15.94%
EPS 3YN/A
EPS 5Y14.33%
EPS growth Q2Q10.29%
Revenue 1Y (TTM)5.77%
Revenue growth 3Y13.79%
Revenue growth 5Y2.51%
Revenue growth Q2Q9.06%

3.2 Future

The Earnings Per Share is expected to grow by 3.46% on average over the next years.
The Revenue is expected to grow by 2.15% on average over the next years.
EPS Next Y-10.38%
EPS Next 2Y-0.68%
EPS Next 3Y3.46%
EPS Next 5YN/A
Revenue Next Year-2.41%
Revenue Next 2Y0.79%
Revenue Next 3Y2.15%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 9.29, the valuation of BLMN can be described as reasonable.
Based on the Price/Earnings ratio, BLMN is valued cheaply inside the industry as 92.54% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 24.76, BLMN is valued rather cheaply.
The Price/Forward Earnings ratio is 10.37, which indicates a very decent valuation of BLMN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BLMN indicates a rather cheap valuation: BLMN is cheaper than 92.54% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 21.26. BLMN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 9.29
Fwd PE 10.37

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BLMN is valued cheaper than 88.81% of the companies in the same industry.
88.06% of the companies in the same industry are more expensive than BLMN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.31
EV/EBITDA 5.46

4.3 Compensation for Growth

The decent profitability rating of BLMN may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.65
EPS Next 2Y-0.68%
EPS Next 3Y3.46%

5

5. Dividend

5.1 Amount

BLMN has a Yearly Dividend Yield of 3.55%. Purely for dividend investing, there may be better candidates out there.
BLMN's Dividend Yield is rather good when compared to the industry average which is at 2.55. BLMN pays more dividend than 91.79% of the companies in the same industry.
BLMN's Dividend Yield is a higher than the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 3.55%

5.2 History

The dividend of BLMN is nicely growing with an annual growth rate of 21.41%!
BLMN has been paying a dividend for over 5 years, so it has already some track record.
BLMN has decreased its dividend recently.
Dividend Growth(5Y)21.41%
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

BLMN pays out 33.85% of its income as dividend. This is a sustainable payout ratio.
The dividend of BLMN is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP33.85%
EPS Next 2Y-0.68%
EPS Next 3Y3.46%

BLOOMIN' BRANDS INC

NASDAQ:BLMN (4/19/2024, 7:00:02 PM)

After market: 27.04 0 (0%)

27.04

+0.01 (+0.04%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.35B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 3.55%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 9.29
Fwd PE 10.37
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)0.65
Profitability
Industry RankSector Rank
ROA 7.22%
ROE 60.46%
ROCE
ROIC
ROICexc
ROICexgc
OM 7.8%
PM (TTM) 5.3%
GM 69.83%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 1.93
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.34
Quick Ratio 0.27
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)15.94%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-10.38%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)5.77%
Revenue growth 3Y13.79%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y